Stenting generally refers to interventional therapy. Interventional therapy itself generally has no effect on a patient’s life expectancy. There is no standardized answer to the question of how long a patient can live after cardiac intervention, as it is generally affected by the patient’s primary condition, the presence of comorbidities and complications, age, and follow-up treatments.
Cardiac stents are generally used for people with angina pectoris, myocardial infarction and other coronary heart diseases. The treatment of coronary heart disease includes antiplatelet therapy with aspirin and clopidogrel, myocardial ischemia therapy with nitrates, lipid regulation with statins, and the decision of whether or not to intervene is based on the characteristics of the lesion and the clinical features of the patient. Interventional therapy generally has no effect on the life expectancy of patients.
Risk factors for poor prognosis after intervention include advanced age, hypertension, high cardiac function class, low left ventricular ejection fraction, diabetes mellitus, smoking, and obesity. Adverse prognostic events include readmission, sudden cardiac death, and arrhythmias.
If you want to avoid the occurrence of adverse events after cardiac stenting, you should follow the doctor’s instructions to standardize the dual antiplatelet therapy, and use the medication in full time and full dosage; patients should maintain a healthy lifestyle, quit smoking and drinking, and those who are obese should lose weight and reduce their fat intake; those who have diabetes mellitus and hypertension should standardize the treatment and control their blood pressure and blood glucose; and at the same time, they should have a good mindset.